Searchable abstracts of presentations at key conferences in endocrinology

ea0038oc1.1 | Early Career Oral Communications | SFEBES2015

A novel pharmacological approach to target LH and testosterone hypersecretion in women with polycystic ovary syndrome: a randomised, double-blind, placebo-controlled multi-centre randomised clinical trial of the neurokinin B receptor antagonist AZD4901

George Jyothis , Kakkar Rahul , Marshall Jayne , Scott Martin , Finkelman Richard , Ho Tony , McIntosh Stuart , Veldhuis Johannes , Skorupskaite Karolina , Anderson Richard , Webber Lorraine

LH hyper-secretion, driven by increased GnRH pulsatility, underpins excess testosterone secretion – a key clinical feature of PCOS.The kisspeptin-neurokinin B (NKB)-GnRH pathway has emerged as the pivotal regulator of reproduction. We hypothesised that pharmacologic blockade of NKB may address the central pathophysiology of LH hyper-secretion and hyperandrogenism in PCOS. We undertook a randomised, double blind, placebo-controlled multi-centre Phase...